Hing-Kin Chan

ProBioGen AG operates as a contract development and manufacturing organization. It specializes in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. The firm offers services such as cell line development, process development, manufacturing programs, physio-chemical analyses, and cell-based assays. The company was founded by Uwe Marx on June 13, 1994 and is headquartered in Berlin, Germany.

Merrion Pharmaceuticals Plc engages in the development of oral forms of drugs which have suboptimal absorption. It also invests in companies focusing in the healthcare sector. The company was founded by Michael Mary Donnelly in December 2003 and is headquartered in Dublin, Ireland.

The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010.

Eurand SpA is a specialty pharmaceutical company that develops, manufactures, and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies. With integrated manufacturing and R&D facilities in the U.S. and Europe, the company has partnered with pharmaceutical companies licensing its four primary technology platforms: Customized Drug Release, Bioavailability Enhancement, Taste Masking or Oral Disintegrating Tablets, and Drug Conjugation. The company is headquartered in Pessano con Bornago, Italy.

Colorcon, Inc. develops and supplies pharmaceutical film coatings and formulation. It offers film coating systems, modified release technologies and functional excipients, as well as tablet design services which enable pharmaceutical companies to distinguish their tablets through color, shape, high-definition imaging, special coatings, flavors and product security identifiers. The company was founded in 1961 and is headquartered in Harleysville, PA.

IDEA AG develops pain therapeutics and biopharmaceutical drugs. The firm develops and commercializes non-invasive therapeutic drugs and the targeted pain therapeutics for arthritic and osteoporosis-related inflammation, chronic pain and diseases. Its technology platform is based on proprietary carriers applied on skin and engineered to diminish side effects and increase drug potency. The company founded by Gregor Cevc in 1993 and is headquartered in Munich, Germany.

Riboxx GmbH operates as a biotechnology company. Its expertise is to design, engineer and manufacture ribonucleic acid (RNA). The company was founded by Jacques Rohayem on May 7, 2009 and is headquartered in Dresden, Germany.